Earnings Per Share
Continuing operations (in dollars per share)
Pfizer Continuing operations (in dollars per share) decreased by 22.6% to $0.48 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.7%, from $0.52 to $0.48. Over 2 years (FY 2021 to FY 2024), Continuing operations (in dollars per share) shows a downward trend with a -40.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionEarnings Per Share
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
Higher values indicate better profitability per share, signaling strong core business performance.
Detailed definition
This metric measures the portion of a company's profit from continuing operations allocated to each share of common stoc...
Peer comparison
Standard EPS metric reported by all public companies.
Metric ID:
eps_income_loss_from_continuing_operations_per_basic_shareHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.04 | $1.45 | $0.63 | $1.40 | $1.76 | $1.54 | $0.89 | $0.98 | $0.41 | -$0.42 | $0.55 | $0.01 | $0.79 | $0.07 | $0.52 | $0.51 | $0.62 | $0.48 |
| QoQ Change | — | +39.4% | -56.6% | +122.2% | +25.7% | -12.5% | -42.2% | +10.1% | -58.2% | -202.4% | +231.0% | -98.2% | >999% | -91.1% | +642.9% | -1.9% | +21.6% | -22.6% |
| YoY Change | — | — | — | — | +69.2% | +6.2% | +41.3% | -30.0% | -76.7% | -127.3% | -43.9% | -97.6% | +288.1% | — | -5.5% | >999% | -21.5% | -7.7% |
Range-$0.42 – $1.76
CAGR-16.6%
Avg YoY Growth+384.2%
Median YoY Growth-7.7%
Continuing operations (in dollars per share) at Other Companies
Frequently Asked Questions
- What is Pfizer's continuing operations (in dollars per share)?
- Pfizer (PFE) reported continuing operations (in dollars per share) of $0.48 in Q1 2026.
- How has Pfizer's continuing operations (in dollars per share) changed year-over-year?
- Pfizer's continuing operations (in dollars per share) decreased by 7.7% year-over-year, from $0.52 to $0.48.
- What is the long-term trend for Pfizer's continuing operations (in dollars per share)?
- Over 2 years (2021 to 2024), Pfizer's continuing operations (in dollars per share) has grown at a -40.3% compound annual growth rate (CAGR), from $3.99 to $1.42.
- What does continuing operations (in dollars per share) mean?
- The profit from ongoing business operations earned for each basic share of stock.